FY2026 EPS Estimates for aTyr Pharma, Inc. (NASDAQ:LIFE) Boosted by HC Wainwright

aTyr Pharma, Inc. (NASDAQ:LIFE – Get Rating) – Research analysts at HC Wainwright upped their FY2026 EPS estimates for shares of aTyr Pharma in a report issued on Wednesday, May 10th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of $0.68 per share for the year, up from their […]

Related Keywords

Canada ,San Diego ,California ,United States ,Paul Schimmel ,Roth Mkm ,Piper Sandler ,Tyr Pharma Company Profile ,Tower Research Capital ,Virtu Financial ,York Mellon Corp ,Nasdaq ,Royal Bank ,Atyr Pharma Inc ,Tyr Pharma ,Get Rating ,Tyr Pharma Price ,Street Group ,New York Mellon Corp ,Research Capital ,Tyr Pharma Company ,Xiang Lei Yang ,Bruce Beutler ,Tyr Pharma Daily ,Atyr Pharma ,Nasdaq Life ,Life ,Medical ,53217v10 ,Earnings Estimates ,Hc Wainwright ,